Loading
Latest filing published 01 Jul 2021 for Graphite Bio, Inc., €84k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
One trade, one date: on 1 July 2021, Smital Shah disclosed an open-market purchase of €84k in LENZ Therapeutics, Inc. No broader history exists yet. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration